KemPharm, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
19.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.19
|
-0.06
|
-46.15%
|
|
2022-06-30
|
-0.12
|
-0.70
|
-0.58
|
-483.33%
|
|
2022-03-31
|
-0.05
|
-0.05
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.07
|
-0.08
|
-0.01
|
-14.29%
|
|
2021-09-30
|
-0.07
|
-0.05
|
0.02
|
28.57%
|
|
2021-06-30
|
0.23
|
0.21
|
-0.02
|
-8.70%
|
|
2021-03-31
|
-0.17
|
-0.54
|
-0.37
|
-217.65%
|
|
2020-12-31
|
-0.64
|
-1.07
|
-0.43
|
-67.19%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.94
|
|
2021-12-31
|
-0.46
|
|
2020-12-31
|
-3.47
|
|
2019-12-31
|
-11.84
|
|
2018-12-31
|
-6.82
|
|
2017-12-31
|
-2.68
|
|
2016-12-31
|
-2.38
|
|
2015-12-31
|
-6.27
|